Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide: Laboratory investigation

Journal of Neurosurgery

Volumn 113, Issue 2, 2010, Pages 234-239

  Sheehan, Jason ^a   Cifarelli, Christopher P ^a   Dassoulas, Kasandra ^a   Olson, Claire ^a   Rainey, Jessica ^a   Han, Shaojie ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Diffusion; Glioblastoma; Oxygen; Radiosensitization; Temozolomide; Trans sodium crocetinate

Indexed keywords

CAROTENOID; RADIOSENSITIZING AGENT; TEMOZOLOMIDE; TRANS SODIUM CROCETINATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER SURVIVAL; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG POTENTIATION; DRUG RESPONSE; GLIOBLASTOMA; GLIOMA; HYPOXIC CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN DIFFUSION; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DACARBAZINE; DIFFUSION; DISEASE MODELS, ANIMAL; GLIOBLASTOMA; HYPOXIA, BRAIN; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; NEOPLASM TRANSPLANTATION; OXYGEN; RADIATION-SENSITIZING AGENTS; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN A;

EID: 77955652081     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2009.11.JNS091314     Document Type: Article

References (35)

1. Abramoff MD, Magelhaes PJ, Ram SJ: Image processing with Image J. Biophotonics International 11:36-42, 2004
2. Barth RF: Rat brain tumor models in experimental neurooncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol 36:91-102, 1998
3. Barth RF, Kaur B: Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J Neurooncol 94:299-312, 2009
4. Burton EC, Prados MD: Malignant gliomas. Curr Treat Options Oncol 1:459-468, 2000
5. Butowski NA, Sneed PK, Chang SM: Diagnosis and treatment of recurrent high-grade astrocytoma. J Clin Oncol 24:1273-1280, 2006 (Pubitemid 46622030)
6. Chapman JD, Reuvers AP, Borsa J, Greenstock CL: Chemical radioprotection and radiosensitization of mammalian cells growing in vitro. Radiat Res 56:291-306, 1973
7. Chowdhury SK, Laudicina D, Blumenkrantz N, Wirth M, Alton KB: An LC/MS/MS method for the quantitation of MTIC (5-(3-N-methyltriazen-1-yl)-imidazole-4- carboxamide), a bioconversion product of temozolomide, in rat and dog plasma. J Pharm Biomed Anal 19:659-668, 1999 (Pubitemid 29092770)
8. Coleman CN, Turrisi AT: Radiation and chemotherapy sensitizers and protectors. Crit Rev Oncol Hematol 10:225-252, 1990
9. Diringer MN: Hyperoxia: good or bad for the injured brain? Curr Opin Crit Care 14:167-171, 2008
10. Ezhilarasan R, Mohanam I, Govindarajan K, Mohanam S: Glioma cells suppress hypoxia-induced endothelial cell apoptosis and promote the angiogenic process. Int J Oncol 30: 701-707, 2007
11. Farrell CL, Stewart PA, Del Maestro RF: A new glioma model in rat: the C6 spheroid implantation technique permeability and vascular characterization. J Neurooncol 4:403-415, 1987
12. Fisher T, Galanti G, Lavie G, Jacob-Hirsch J, Kventsel I, Zeligson S, et al: Mechanisms operative in the antitumor activity of temozolomide in glioblastoma multiforme. Cancer J 13: 335-344, 2007
13. Friedman HS, Dolan ME, Pegg AE, Marcelli S, Keir S, Catino JJ, et al: Activity of temozolomide in the treatment of central nervous system tumor xenografts. Cancer Res 55:2853-2857, 1995
14. Gainer JL: Trans-sodium crocetinate for treating hypoxia/ ischemia. Expert Opin Investig Drugs 17:917-924, 2008
15. Gainer JL, Stennett AK, Murray RJ: The effect of trans sodium crocetinate (TSC) in a rat oleic acid model of acute lung injury. Pulm Pharmacol Ther 18:213-216, 2005
16. Giassi LJ, Gilchrist MJ, Graham MC, Gainer JL: Trans-sodium crocetinate restores blood pressure, heart rate, and plasma lactate after hemorrhagic shock. J Trauma 51:932-938, 2001
17. Grobben B, De Deyn PP, Slegers H: Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res 310:257-270, 2002 (Pubitemid 35435769)
18. Kang SG, Kim JS, Park K, Kim JS, Groves MD, Nam DH: Combination celecoxib and temozolomide in C6 rat glioma orthotopic model. Oncol Rep 15:7-13, 2006
19. Kaur B, Tan C, Brat DJ, Post DE, Van Meir EG: Genetic and hypoxic regulation of angiogenesis in gliomas. J Neurooncol 70:229-243, 2004 (Pubitemid 39545734)
20. Khan N, Li H, Hou H, Lariviere JP, Gladstone DJ, Demidenko E, et al: Tissue pO2 of orthotopic 9L and C6 gliomas and tumor-specific response to radiotherapy and hyperoxygenation. Int J Radiat Oncol Biol Phys 73:878-885, 2009
21. Kondziolka D, Lunsford LD, Claassen D, Maitz AH, Flickinger JC: Radiobiology of radiosurgery: Part I. The normal rat brain model. Neurosurgery 31:271-279, 1992
22. Korkolopoulou P, Perdiki M, Thymara I, Boviatsis E, Agrogiannis G, Kotsiakis X, et al: Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX. Hum Pathol 38:629-638, 2007
23. Okonkwo DO, Wagner J, Melon DE, Alden T, Stone JR, Helm GA, et al: Trans-sodium crocetinate increases oxygen delivery to brain parenchyma in rats on oxygen supplementation. Neurosci Lett 352:97-100, 2003 (Pubitemid 37415134)
24. Proescholdt MA, Mayer C, Kubitza M, Schubert T, Liao SY, Stanbridge EJ, et al: Expression of hypoxia-inducible carbonic anhydrases in brain tumors. Neuro Oncol 7:465-475, 2005 (Pubitemid 41555618)
25. Roberts DA, Detre JA, Bolinger L, Insko EK, Leigh JS Jr: Quantitative magnetic resonance imaging of human brain perfusion at 1.5 T using steady-state inversion of arterial water. Proc Natl Acad Sci U S A 91:33-37, 1994 (Pubitemid 24018637)
26. Rong Y, Durden DL, Van Meir EG, Brat DJ: 'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropathol Exp Neurol 65:529-539, 2006 (Pubitemid 44288937)
27. Saito R, Bringas JR, Panner A, Tamas M, Pieper RO, Berger MS, et al: Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model. Cancer Res 64:6858-6862, 2004 (Pubitemid 39330991)
28. Sheehan J, Ionescu A, Pouratian N, Hamilton DK, Schlesinger D, Oskouian RJ Jr, et al: Use of trans sodium crocetinate for sensitizing glioblastoma multiforme to radiation: laboratory investigation. J Neurosurg 108:972-978, 2008 (Pubitemid 351656846)
29. Sheehan J, Sherman J, Cifarelli C, Jagannathan J, Dassoulas K, Olson C, et al: Effect of trans sodium crocetinate on brain tumor oxgenation. Laboratory investigation. J Neurosurg 111: 226-229, 2009
30. Shrieve DC, Klish M, Wendland MM, Watson GA: Basic principles of radiobiology, radiotherapy, and radiosurgery. Neurosurg Clin N Am 15:467-479, x, 2004
31. Spence AM, Muzi M, Swanson KR, O'Sullivan F, Rockhill JK, Rajendran JG, et al: Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival. Clin Cancer Res 14:2623-2630, 2008
32. Stennett AK, Dempsey GL, Gainer JL: trans-Sodium crocetinate and diffusion enhancement. J Phys Chem B 110:18078-18080, 2006
33. Stewart C, Haitsma I, Zador Z, Hemphill JC III, Morabito D, Manley G III, et al: The new Licox combined brain tissue oxygen and brain temperature monitor: assessment of in vitro accuracy and clinical experience in severe traumatic brain injury. Neurosurgery 63:1159-1165, 2008
34. Sugiyama S, Yamashita Y, Kikuchi T, Sonoda Y, Kumabe T, Tominaga T: Enhanced antitumor effect of combined-modality treatment using convection-enhanced delivery of hydrophilic nitrosourea with irradiation or systemic administration of temozolomide in intracranial brain tumor xenografts. Neurol Res 30:960-967, 2008
35. Zagzag D, Lukyanov Y, Lan L, Ali MA, Esencay M, Mendez O, et al: Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Invest 86:1221-1232, 2006 (Pubitemid 44789912)